Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden
· Delayed Price · Currency is SEK 4.480
-0.140 (-3.03%)
Apr 28, 2026, 5:09 PM CET
STO:MAGLE Revenue
In the year 2025, Magle Chemoswed Holding AB had annual revenue of 287.55M SEK with 19.53% growth. Magle Chemoswed Holding AB had revenue of 76.03M in the quarter ending December 31, 2025, a decrease of -14.54%.
Revenue
287.55M
Revenue Growth
+19.53%
P/S Ratio
0.32
Revenue / Employee
2.00M
Employees
140
Market Cap
92.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biovica International AB | 10.93M |
| OncoZenge AB | 2.78M |
| Scandinavian ChemoTech AB | 12.29M |
| AcouSort AB | 10.43M |
| Simris Group AB (PUBL) | 1.62M |
| Spago Nanomedical AB | 4.82M |
| Alzinova AB | 26.80M |
| IRLAB Therapeutics AB | 57.46M |
Magle Chemoswed Holding AB News
- 3 years ago - Magle Chemoswed Holding AB Earnings Call Transcript: Q3 2022 - Transcripts
- 4 years ago - Magle Chemoswed Holding AB Earnings Call Transcript: Q2 2022 - Transcripts